Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera.


Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 28 02 2020
accepted: 04 06 2020
revised: 26 05 2020
pubmed: 10 6 2020
medline: 11 11 2020
entrez: 10 6 2020
Statut: ppublish

Résumé

Chronic kidney disease (CKD) is a well-known risk factor for venous thromboembolism and cardiovascular (CV) disease development in the general population, but its role in thrombotic risk in essential thrombocythemia (ET) and polycythemia vera (PV) remains poorly understood. This retrospective multicenter study analyzed clinical correlations and the potential impact of CKD on thrombosis development in ET and PV patients. We included 167 patients (76 ET and 91 PV); 25.7% had CKD at diagnosis, defined as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m

Identifiants

pubmed: 32514928
doi: 10.1007/s12185-020-02898-7
pii: 10.1007/s12185-020-02898-7
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-384

Auteurs

Ivan Krečak (I)

Department of Internal Medicine, Šibenik-Knin County General Hospital, Stjepana Radića 83, 22000, Šibenik, Croatia. krecak.ivan@gmail.com.

Hrvoje Holik (H)

Department of Internal Medicine, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia.
School of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.

Morić Perić Martina (MP)

Department of Internal Medicine, Zadar General Hospital, Zadar, Croatia.

Ivan Zekanović (I)

Department of Internal Medicine, Zadar General Hospital, Zadar, Croatia.

Božena Coha (B)

Department of Internal Medicine, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia.

Velka Gverić-Krečak (V)

Department of Internal Medicine, Šibenik-Knin County General Hospital, Stjepana Radića 83, 22000, Šibenik, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH